This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eilber, F. C. Articles by Singer, S. Search for Related Content PubMed PubMed Citation Articles by Eilber, F. C. Articles by Singer, S.

Prognostic Factors for Survival in Patients With Locally Recurrent Extremity Soft Tissue Sarcomas

¹ Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
² Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
³ Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021
⁴ Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021

Correspondence: Address correspondence and reprint requests to: Samuel Singer, MD; E-mail: singers{at}mskcc.org.

Background: Factors prognostic for survival in patients with locally recurrent extremity soft tissue sarcomas (STS) are poorly defined, thus making it difficult to identify high-risk patients who may benefit from adjuvant therapy.

Methods: A total of 1421 patients underwent surgical treatment for primary extremity STS at a single institution between 1982 and 2002. Of these, 179 (13%) patients underwent complete surgical resection of an isolated local recurrence and were the subjects of this study. Clinicopathologic factors from both the primary tumor and the local recurrence were analyzed.

Results: The median interval to initial local recurrence was 16 months: 65% developed a local recurrence by 2 years and 90% by 4 years. Only four patients who presented with a low-grade primary tumor progressed to a high-grade local recurrence. Independent prognostic factors for disease-specific survival after local recurrence were a high histological grade (hazard ratio, 5.1; P = .0004), a large local recurrence tumor size (hazard ratio, 1.5; P = .0001), and a short local recurrence–free interval (hazard ratio, 1.6; P = .0001). Patients who developed a local recurrence >5 cm in 16 months (n = 44; 0 low grade) had a 4-year disease-specific survival of 18%, compared with 81% for patients who developed a local recurrence 5 cm in >16 months (n = 46; 11 low grade).

Conclusions: Histological grade, local recurrence size, and local recurrence–free interval are independently predictive of survival in patients with locally recurrent extremity STS. A large local recurrence that develops in a short interval indicates a biologically aggressive tumor with a high tumor-specific mortality. Patients who develop such recurrences are ideal subjects for systemic neoadjuvant therapy trials.

Key Words: Local recurrence • Extremity soft tissue sarcoma • Prognostic factors • Adjuvant therapy

This article has been cited by other articles:

				M. F. Brennan Local Recurrence in Soft Tissue Sarcoma: More About the Tumor, Less About the Surgeon Ann. Surg. Oncol., May 1, 2007; 14(5): 1528 - 1529. [Full Text] [PDF]

				A. Gronchi, R. Miceli, M. Fiore, P. Collini, L. Lozza, F. Grosso, L. Mariani, and P. G. Casali Extremity Soft Tissue Sarcoma: Adding to the Prognostic Meaning of Local Failure Ann. Surg. Oncol., May 1, 2007; 14(5): 1583 - 1590. [Abstract] [Full Text] [PDF]